In 2023, the trade exchange (includes international purchases and sales) of Vitamin E and its Derivatives Used Primarily as Vitamins was US$51.2M.
In 2023, the states with the most international sales in Vitamin E and its Derivatives Used Primarily as Vitamins were Jalisco (US$708k), Ciudad de México (US$129k), and Estado de México (US$36.2k).
The states with the most international purchases in 2023 were Jalisco (US$22M), Ciudad de México (US$17.6M), Querétaro (US$8.01M), Estado de México (US$231k), and Guanajuato (US$86.4k).
In 2023, the main commercial destinations of Vitamin E and its Derivatives Used Primarily as Vitamins were Dominican Republic (US$210k), Costa Rica (US$131k), El Salvador (US$99.6k), Guatemala (US$97k), and Argentina (US$96k).
The main commercial origins of Vitamin E and its Derivatives Used Primarily as Vitamins in 2023 were China (US$21.3M), United States (US$12.9M), Germany (US$7.79M), Switzerland (US$4.57M), and France (US$895k).
In the global context, the main exporting countries of Vitamin E and its Derivatives Used Primarily as Vitamins in 2022 were China (US$1.01B), Switzerland (US$370M), and Germany (US$364M). In the same year, the main importing countries of Vitamin E and its Derivatives Used Primarily as Vitamins were United States (US$477M), Germany (US$305M), and Netherlands (US$168M).